Influence of Restitution Time in Treatment of Patellar Tendinopathy (NCT05731037) | Clinical Trial Compass
Active ā Not RecruitingNot Applicable
Influence of Restitution Time in Treatment of Patellar Tendinopathy
Denmark52 participantsStarted 2023-03-02
Plain-language summary
The purpose of the present project is to investigate if the restitution time from loading in an exercise-based 12 weeks rehabilitation regime for patellar tendinopathy influences the clinical outcome, tendon structure and function.
The investigators hypothesize that greater restitution from loading (1 exercise day per week) will yield a greater positive clinical outcome, and tissue structure and function in patients with patellar tendinopathy compared to less restitution (3 exercise days per week), when impact activities are restricted in both groups.
Who can participate
Age range18 Years ā 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sports active men and women.
* Age (18-60) years old.
* BMI (18.5-30)
* Understand and read Danish
* Uni- or bilateral patellar tendinopathy
* Symptom onset \>90 days ago
Exclusion Criteria:
* Patellar tendinopathy longer than 24 months
* Smoking
* Previous surgery in the knee on the ipsilateral side.
* Corticosteroid injection in the patellar tendon on the ipsilateral side within the last 6 months.
* Any confounding diagnosis to the knee joint
* Known arthritis
* Known diabetes
* Inability to follow rehabilitation or complete follow-ups
* Enrolled in a resistance based-rehabilitation program for the affected patellar tendon within the previous three month
* Have a work were it is not feasible to avoid pain provoking tasks
Extra criteria sub-study one
Inclusion criteria:
ā¢ Five patients from the main study, rating "improved" and "not improved" respectively, will be invited to participate in sub-study one.
Exclusion criteria:
* Claustrophobia
* Pregnancy
* Breastfeeding
Extra criteria sub-study two:
Inclusion criteria:
* Patients from the main study, that rate themselves 'not improved' in symptoms after 12 week.
* Patients who have not achieved Patient Acceptable Symptom State (PASS) after week 20, 24, 28, 32, 36 and 40, will be invited to participate in sub- study two.
Exclusion criteria:
* Pregnancy
* Breastfeeding
* Previously had an allergic reaction for steroid (Depomedrol).
* Previously had an allergic reaction for local anesthesia treaā¦